LAWSON MACARTNEY - 08 Nov 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau as Attorney-in-Fact
Issuer symbol
VKTX
Transactions as of
08 Nov 2024
Net transactions value
-$125,733
Form type
4
Filing time
08 Nov 2024, 18:22:28 UTC
Previous filing
04 Jan 2024
Next filing
06 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $11,600 +2,000 +4.2% $5.80 49,965 08 Nov 2024 Direct
transaction VKTX Common Stock, par value $0.00001 per share Sale $137,333 -2,000 -4% $68.67 47,965 08 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -2,000 -9.1% $0.000000 20,000 08 Nov 2024 Common Stock 2,000 $5.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.